Skip to main content

Affy's Restructuring Charges Topped Most Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, May 16.
1. Affymetrix Expecting 2008 Restructuring Charges of $15.4M (from May 12)
2. 23andMe Inks Collaboration with Parkinson's Institute (from May 14)
3. Genomic Standards Consortium Issues Guidelines (from May 13)
4. Invitrogen Launches Cell Therapy Unit (from May 16)
5. Cepheid Signs Group Purchasing Deal with Premier (from May 12) 
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.